Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Press Releases
deCODE genetics Announces Second Quarter 2009 Financial Results
deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2009 Financial Results
deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke
It's Not Just the Sun: deCODE Discovers Sequence Variants Affecting Susceptibility to Skin Cancer
deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia
deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis
deCODE Reinstated to Nasdaq Global Market
deCODE Genotyping Laboratory Receives College of American Pathologists Accreditation
deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease
deCODE genetics Announces First Quarter 2009 Financial Results
deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2009 Financial Results
Nasdaq Stays Suspension of Trading in deCODE Stock
deCODE and Celera Partner to Expand Use of deCODE Risk Markers for Heart Attack, Stroke and Diabetes
deCODE to Utilize Grace Period for Interest Payment on Senior Convertible Notes
Zacks Analyst Blog Highlights: deCODE Genetics, The St. Joe Company, General Motors Corp., Daimler AG and American Electric Power Co., Inc.
deCODE genetics Announces Full-year 2008 Financial Results
deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2008 Financial Results
deCODE Receives California Clinical Laboratory License
Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack
deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Assessment and Earlier Intervention
deCODE Announces Transfer of the Listing of its Common Stock from Nasdaq Global Market to Nasdaq Capital Market
deCODEme(TM) Takes on Heart Disease in February
deCODE Discovers First Genetic Variant Conferring Increased Risk of Essential Tremor
deCODE Sells Auction Rate Securities
A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
Introducing deCODEme Cardio(TM) and deCODEme Cancer(TM)
Stories From Our Foremothers: deCODE Publishes an Unparalleled Genetic Snapshot of Iceland 1000 Years Ago
deCODE Discovers Common Genetic Variations Contributing to Low Bone Mineral Density and Risk of Osteoporosis
Major deCODE-led Study Underscores Role of the Brain in Obesity
deCODE to Integrate New Genetic Risk Factor for Type 2 Diabetes Into Its deCODEme(TM) Personal Genome Scan Service
Major Independent Study Underscores Utility of deCODE MI(TM) for Better Predicting Risk of Heart Attack, Informing Statin Therapy
deCODE Study Expands Clinical Utility of deCODE AF(TM) for Improving the Diagnosis of Atrial Fibrillation and Preventing Stroke
deCODE genetics Announces Third Quarter 2008 Financial Results
deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2008 Financial Results
deCODE Conducting Strategic Review to Sharpen the Focus of its Long-term Business
deCODE Discovery Sheds Light on Risk of the Most Common Form of Skin Cancer
deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer
deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Most Common Forms of Breast Cancer
deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders
deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
deCODE genetics to Webcast Presentation at Thomas Weisel Partners Healthcare Conference 2008
deCODE genetics Announces Second Quarter 2008 Financial Results
deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2008 Financial Results
deCODE and SGENE Consortium Discover Deletions in the Human Genome Linked to Risk of Schizophrenia
BeaconEquity.com Issues Technical Trade Alerts on Market Movers: LVLT, ISRG, JBLU, SBUX, TSFG, DCGN
Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event
deCODE genetics to Webcast Presentations at Annual R&D Event - Jun 30 2008 9:28AM
DG041 Blocks Platelet Aggregation Through a Novel Mechanism and does not Increase Bleeding Time When Given Alone or with Plavix(TM) or Aspirin
deCODE genetics to Webcast Presentations at Annual R&D Event - Jun 25 2008 7:39AM
deCODE genetics to Webcast Presentation at Piper Jaffray Europe Conference
deCODE genetics Announces First Quarter 2008 Financial Results - Jun 1 2008 5:23PM
deCODE Discovers Genetic Variants Influencing Bone Mineral Density
deCODE Discovers Fourth Major Set of Common Genetic Variants Linked to Risk of Estrogen Receptor-Positive Breast Cancer
deCODE Lauds Federal Legislation to Ban Discrimination on the Basis of Genetic Information
deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results
A Smoking Gene: deCODE Shows How a Single Variant in the Sequence of the Genome Confers Nicotine Dependence and Risk of Lung Cancer and Other Disease
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia